Elution of gentamicin and vancomycin from polymethylmethacrylate beads and hip spacers in vivo

Konstantinos Anagnostakos, Philippe Wilmes, Eduard Schmitt, Jens Kelm, Konstantinos Anagnostakos, Philippe Wilmes, Eduard Schmitt, Jens Kelm

Abstract

Background and purpose: Late infections after total hip arthroplasty are still a problem. Treatment procedures include resection arthroplasty with implantation of antibiotic-loaded beads or implantation of an antibiotic-impreganted spacer. However, little is known about antibiotic elution from bone cement beyond the first 2-3 postoperative days in humans.

Methods: 17 hip spacers (80 g PMMA, 1g gentamicin, and 4 g vancomycin) and 11 chains (40 g PMMA, 0.5 g gentamicin, and 2 g vancomycin) in 28 patients were studied. The release of both agents was measured in the drainage fluid on a daily basis. The drains were left in situ until less than 50 mL was produced per day. The elution of both antibiotics was determined by fluorescence polarization immunoassay. Systemic antibiotics were given postoperatively according to antibiogram. If possible, no gentamicin or vancomycin was given.

Results: Peak mean concentrations from beads and spacers were reached for gentamicin (1,160 (12-371) microg/mL and 21 (0.7-39) microg/mL, respectively) and for vancomycin (80 (21-198) microg/mL and 37 (3.3-72) microg/mL) on day 1. The last concentrations to be determined were 3.7 microg/mL gentamicin and 23 microg/mL vancomycin in the beads group after 13 days, and 1.9 microg/mL gentamicin and 6.6 microg/mL vancomycin in the spacer group after 7 days. Between the fifth and seventh day, an intermittent increase in elution of vancomycin from both beads and spacers and of gentamicin from spacers was noticed. No renal or hepatic dysfunction was observed.

Interpretation: Beads showed higher elution characteristics in vivo than the spacers due to their larger surface area; however, a great amount of inter-subject variability was seen for both beads and spacers. The inferior elution properties of spacers emphasize the importance of additional systemic antibiotics for this treatment procedure during the postoperative period. Future studies should clarify whether the dose of antibiotics or length of antibiotic therapy may be reduced in the case of bead implantation, without jeopardizing the control of infection.

Figures

Figure 1.
Figure 1.
Gentamicin- and vancomycin-impregnated spacer in situ. The elution of antibiotics was determined using the wound drainage placed at the head of the spacer.
Figure 2.
Figure 2.
Elution of gentamicin and vancomycin from beads over the first 13 postoperative days. Mean and extreme values (minimum-maximum) are shown for each day.
Figure 3.
Figure 3.
Elution of gentamicin and vancomycin from spacers over the first 7 postoperative days. Mean and extreme values (minimum-maximum) are shown for each day.
Figure 4.
Figure 4.
The elution from the spacers showed substantial inter-individual variability in the peak amounts of antibiotic released during the first postoperative days.
Figure 5.
Figure 5.
The release of antibiotic from beads also showed substantial inter-individual variability for both agents regarding the peak amounts of antibiotic released during the first postoperative days.

References

    1. Adams K, Couch L, Cierny G, Calhoun J, Mader JT. In vitro an din vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop. 1992;(278):244–52.
    1. Anagnostakos K, Kelm J, Regitz T, Schmitt E, Jung W. In vitro evaluation of antibiotic release from and bacterai growth inhibition by antibiotic-loaded acrylic bone cement spacers. J Biomed Mater Res B Appl Biomater. 2005;72(2):373–8.
    1. Anagnostakos K, Fürst O, Kelm J. Antibiotic-impregnated hip spacers: Current status. Acta Orthop. 2006;77(4):628–37.
    1. Bertazzonni Minelli E, Benini A, Magnan B, Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004;53(2):329–34.
    1. Buchholz HW, Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg. 1970;41(11):511–5.
    1. Chapman MW, Hadley WK. The effect of polymethylmethacrylate and antibiotic combinations on bacterial viability. An in vitro and preliminary in vivo study. J Bone Joint Surg (Am) 1976;58(1):76–81.
    1. Chohfi M, Langlais F, Fourastier J, Minet J, Thomazeau , Cormier M. Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cement. Int Orthop. 1998;22(3):171–7.
    1. Hsieh PH, Shih CH, Chang YH, Lee MS, Shih HN, Yang WE. Two-stage revision hip arthroplasty for infection: comparison between the interim use of antibiotic-loaded cement beads and a spacer prosthesis. J Bone Joint Surg (Am) 2004;86(9):1989–97.
    1. Hsieh PH, Chang YH, Chen SH, Ueng SW, Shih CH. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res. 2006;24(8):1615–21.
    1. Isiklar ZU, Demirors H, Akpinar S, Tandogan RN, Alparslan M. Two-stage treatment of chronic staphylococcal orthopaedic implant-related infections using vancomycin impregnated PMMA spacer and rifampicin containing antibiotic protocol. Bull Hosp Jt Dis. 1999;58(2):79–85.
    1. Jenny JY, Jenny G, Lambert J, Gaudias J, Kempf I. Utility of measurement of gentamicin release from PMMA beads in wound drainage fluid after in-vivo implantation. Acta Orthop Belg. 1995;61(1):10–3.
    1. Kelm J, Anagnostakos K, Regitz T, Schmitt E, Schneider G, Ahlhelm F. MRSA-infections-treatment with intraoperatively produced gentamicin-vancomycin PMMA beads. Chirurg. 2004;75(10):988–95.
    1. Klekamp J, Dawson JM, Haas DW, Deboer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty. 1999;14(3):339–46.
    1. Klemm K. Treatment of chronic bone infection with gentamicin PMMA-chains and beads. Accid Surg. 1976;1:20–5.
    1. Koo K-H, Yang J-W, Cho S-H, Song H-R, Park H-B, Ha Y-C, Chang J-D, Kim S-Y, Kim Y-H. Impregnation of vancomycin, gentamicin and cefotaxime in a cement spacer for two-stage cementless reconstruction in infected total hip arthroplasty. J Arthroplasty. 2001;16(7):882–92.
    1. Masri BA, Duncan CP, Beauchamp CP. Long-term elution of antibiotics from bone-cement. An in-vivo study using the prosthesis of antibiotic-loaded acrylic-cement (PROSTALAC). J Arthroplasty. 1998;13(3):331–8.
    1. McLean AJ, Ioannidesdemos LL, Li SC, Bastone EB, Spicer WJ. Bactericidal effect of gentamicin peak concentration provides a rationale for administration of bolus doses. J Antimicrob Chemother. 1993;32(2):301–5.
    1. Nelson CL, Hickmon SG, Harrison BH. Elution characteristics of gentamicin-PMMA beads after implantation in humans. Orthopedics. 1994;17(5):415–6.
    1. Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother. 2006;40(11):2037–42.
    1. Penner MJ, Masri BA, Duncan CP. Elution characteristics of tobramycin and vancomycin combined in acrylic bone cement. J Arthroplasty. 1996;11(8):939–44.
    1. Salvati EA, Callaghan JJ, Brause BD, Klein RF, Small RD. Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop. 1986;(207):83–93.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi